Clinical Trial Update: Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update comparing atrial fibrillation ablation with a rate-control strategy in patients with persistent atrial fibrillation and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure with Reduced Ejection Fraction

Snippet

Sponsor: University of Turin, Italy | Conditions: Persistent Atrial Fibrillation, Congestive Heart Failure Due to Left Ventricular Systolic Dysfunction | Phase 4 | Status: UNKNOWN